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CancerThe activation of the protein kinase Raf at the cell membrane is a critical step in cell signaling during
development, but the mechanisms that regulate Raf activity remain incompletely deﬁned. We previously
demonstrated that the C. elegans cgr-1 gene encodes a CRAL/TRIO domain-containing protein that is a critical
modulator of Ras-dependent cell fate speciﬁcation during C. elegans development. Here we identify the
mammalian α-tocopherol associated protein-1 (TAP-1) as a functional ortholog of cgr-1. TAP-1 mRNA was
expressed in many tissues, and TAP-1 protein colocalized with Ras and Raf at the cell membrane. Reducing
TAP-1 expression by RNA interference increased Ras/ERK signaling in multiple cell types. These functional
studies demonstrate that CRAL/TRIO domain proteins play a conserved role in regulating Ras signaling.
Biochemical analyses indicated that TAP-1 operates at the level of Raf, since TAP-1 function negatively
regulated the amount of Raf-1 recruited to GTP-bound Ras at the cell membrane. TAP-1 plays a signiﬁcant
physiological role in controlling cell division, since reducing TAP-1 expression increased the oncogenic
capacity of Ras transformed human cancer cell lines. These studies identify TAP-1 as a critical modulator of
Ras-mediated cellular signaling.Golgi dynamics; CRAL/TRIO,
rol associated protein; CGR-1,
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Cell fates are established during development by spatially
controlled activation of signal transduction pathways that regulate
transcription factors. The receptor tyrosine kinase (RTK)/Ras/extra-
cellular-regulated kinase (ERK) signaling pathway is used reitera-
tively during animal development to specify a wide range of cell fates.
The activation of Raf is a critical step in this signaling pathway, but the
molecular requirements for Raf activation still remain largely
unknown. Following ligand binding by Receptor Tyrosine Kinases,
Raf binds to GTP-loaded Ras at the cell membrane and initiates a series
of biochemical reactions. Activated Raf phosphorylates and activates
the mitogen activated ERK kinases, MEK1 and MEK2, which in turn
phosphorylate and activate the extracellular signal activated kinases,
ERK1 and ERK2. Phosphorylated ERK translocates to the nucleus and
affects gene expression through the regulation of transcription factor
phosphorylation (Kolch, 2005). Identifying and characterizing the
proteins involved in this signaling pathway have important implica-
tions for human health, since mutations leading to the constitutive
activation of Raf have been widely implicated in cellular oncogenesis
(Bos, 1989; Ulku and Der, 2003).In C. elegans, this signaling pathway has been extensively
characterized during development of the hermaphrodite vulva, an
epidermal structure for egg laying and sperm entry (Kornfeld, 1997;
Greenwald, 1997). In third larval stage hermaphrodites, six ventral
epidermal blast cells called P3.p–P8.p (Pn.p cells) lie along the
anterior–posterior axis. These Pn.p cells are an equivalence group,
since each cell can adopt the 1° vulval cell fate (eight descendents),
the 2° vulval cell fate (seven descendents), or the non-vulval 3° cell
fate (two descendents). During vulval induction, the anchor cell of the
somatic gonad secretes LIN-3 ligand, an epidermal growth factor
(EGF) homolog, thereby activating the LET-23/RTK on the adjacent
P6.p cell. Activated LET-23 recruits the SEM-5 adaptor (GRB2) and the
LET-341 guanine nucleotide exchange factor (SOS), followed by
sequential activation of the GTPase LET-60 (RAS) and the protein
kinases LIN-45 (RAF), MEK-2 (MEK), and MPK-1 (ERK). Activated
MPK-1 phosphorylates substrates including the LIN-1 ETS transcrip-
tion factor, thereby promoting the 1° fate in P6.p. P6.p signals P5.p and
P7.p to adopt 2° fates by activating a lateral signal involving LIN-12/
Notch. The 22 descendents of P5.p, P6.p and P7.p invaginate and
differentiate to form the vulval structure. P3.p, P4.p and P8.p receive
neither signal and therefore adopt 3° fates. Mutations that reduce
activation of RTK/Ras/ERK signaling cause a vulvaless (Vul) pheno-
type, whereas mutations that constitutively activate this pathway
cause more than three Pn.p cells to adopt the 1° or 2° vulval cell fate,
resulting in a multivulval (Muv) phenotype characterized by ectopic
patches of vulval tissue.
Genetic screens for C. elegansmutants have led to the discovery of
conserved proteins that play functionally signiﬁcant roles in Ras-ERK
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identiﬁed the CRAL/TRIO and GOLD domain suppressor of activated ras
(cgr-1) as a suppressor of the Muv phenotype caused by a mutation
that constitutively actives Ras. Genetic analysis indicated that cgr-1
functions downstream or in parallel to ras, and upstream of the lin-1
ETS domain transcription factor (Goldstein et al., 2006). Precisely
where cgr-1 acts within this pathway is unknown. CRAL/TRIO
domains form hydrophobic binding pockets that bind small hydro-
phobic ligands (Bateman et al., 2000; Sha et al., 1998; Stocker et al.,
2002; Stocker and Baumann, 2003; Panagabko et al., 2003). GOLD
(Golgi dynamics) domains were identiﬁed by protein alignments and
are of unknown function (Stocker et al., 2002; Anantharaman and
Aravind, 2002).
Utilizing proteomic alignment techniques, we identiﬁed three
human proteins with an identical domain structure to CGR-1: TAP-1,
TAP-2 and TAP-3. The prototypic family member, α-tocopherol
associated protein (TAP-1), was identiﬁed by its afﬁnity for α-
tocopherol (Vitamin E) in vitro. Human TAP-2 and TAP-3 are 77% and
70% identical to TAP-1 at the protein level, and all three mammalian
proteins are ∼30% identical to CGR-1 (Goldstein et al., 2006; Kempna
et al., 2003). TAP-1 was originally described as Supernatant Protein
Factor (SPF) based upon its ability to promote the conversion of
squalene to lanosterol by liver microsomes, suggestive of roles in
cholesterol metabolism, although the relevance of this interaction in
vivo is unknown (Zimmer et al., 2000; Tchen and Bloch, 1957; Shibata
et al., 2001). The biological functions of the TAP proteins are not well
deﬁned, and the relevance of the identiﬁed hydrophobic binding
partners remains enigmatic. We hypothesized that the TAP proteins
represent functional orthologs of CGR-1 and regulate signaling
downstream of Ras activation. Accordingly, we demonstrate that
human TAP-1 regulates signaling in vertebrate cells, acting at a
previously uncharacterized step of the Ras pathway by inhibiting the
ability of Raf to translocate to activated Ras at the cell membrane.
These studies also reveal an in vivo function for the TAP family
proteins and identify a new regulator of Ras-mediated signaling.
Materials and methods
Cells, plasmids and antibodies
All cells were purchased from the American Type Culture
Collection (Rockville, MD). HeLa, COS-7, and MDA-MB-231 cells
were maintained in Dulbecco's Modiﬁed Eagles Media supplemented
with 10% heat inactivated FCS, 2 mM L-glutamine, 10 mM sodium
pyruvate, and 50 mM2-mercaptoethanol. A549 cells weremaintained
in Ham's F12K medium with 2 mM-glutamine adjusted to contain
1.5 g/l sodium bicarbonate and 10% heat inactivated FCS. Mouse TAP-
1 cDNA was obtained from ATCC. Wild-type full length TAP-1 was
expressed in pcDNA3.1Zeo+ (Invitrogen, Carlsbad, CA). Plasmids
encoding human wild-type and mutant GFP-tagged H-Ras and K-Ras
were a kind gift of John Hancock (Apolloni et al., 2000). For
biochemical analyses, rabbit anti-Raf-1 and rabbit anti-transferrin
receptor were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA), anti-pan-Ras was purchased from ECB Biosciences, and
anti-phosphoERK, anti-phosphoMEK, anti-ERK and anti-MEK were
purchased from Cell Signaling Technologies (Danvers, MA). Horse-
radish peroxidase-conjugated secondary antibodies were purchased
from Pierce (Rockford, IL).
Expression of TAP mRNA
RNA was extracted from mouse brain, heart, kidney, lung, spleen,
thymus and ES cell cultures using an RNA extraction kit (Qiagen,
Valencia, CA). cDNA was generated using oligo-dT primed Superscript
II Reverse Transcriptase reactions from each tissue. Primers designed
to speciﬁcally amplify TAP-1, TAP-2 or TAP-3 were then used to PCRamplify the input cDNA. Following ethidium bromide stained gel
fractionation, the identity of DNA products from lung tissue was
conﬁrmed by sequencing.
Confocal microscopy
Cells were transfected for 24 h with Flag-TAP-1 and GFP-tagged
Ras or GFP-tagged Raf-1 expression plasmids with lipofectamine 2000
(Invitrogen) and cultured for a further 24 h in complete DMEMmedia.
Cells were placed in 4% paraformaldehyde, permeablized in 0.15%
Triton X-100, and blocked in 1% BSA. Cells were stained with Cy3
conjugated anti-Flag (clone M2, Sigma, St. Louis, MO), washed and
mounted for imaging in Slowfade (Molecular Probes, Eugene, OR).
Digitized two-color ﬂuorescence images were obtained with an
inverted Plan Apochromat ×63/1.4 oil objective on a Zeiss LSM 510
Confocal Microscope.
RNA interference of TAP-1
Human TAP-1 RNAi duplexes were purchased from Dharmacon
(Lafayette, CO). Duplexes; A. Sense GAACACAGCGUGCAGAUUUUU,
Antisense 5'P-UCUCGCACAUAAUACUUCCUU; B. Sense GGAAGGAG-
GUUUUACUGAAUU, Antisense 5'P-UUCAGUAAAACCUCCUUCCUU; C.
Sense GGAAGUAUUAUGUGCGAGAUU; Antisense 5'P-UCUCGCA-
CAUAAUACUUCCUU; Control sense; UAGCGACUAAACACAUCAA. Cells
cultured inOptiMEM(Invitrogen)were transfectedwith100nMofRNAi
duplexusingOligofectamineReagent (Invitrogen), incubatedovernight,
transferred into complete DMEM media for 48 h, and harvested for
analysis or transfected with expression plasmids or analyzed for
anchorage independent growth. Alpha-tocopherol (Sigma, St. Louis,
MO) was solublized in ethanol, dried under Nitrogen, dissolved in
DMSO, incubatedwith fetal calf serum for 30 min at 37 °C, and added to
cell cultures. Cells were exposed to α-tocopherol or DMSO as a control
for the ﬁnal 24 hours of culture.
Biochemical analyses
Cells were lysed in Nonidet P-40 lysis buffer (150 mMNaCl, 50 mM
Tris–HCl, pH 8.0, 25 mM NaF, 1 mM sodium orthovanadate, 0.5%
Nonidet P-40) containing protease inhibitors (Roche Complete Mini,
Indianapolis, IN) and clariﬁed at 13,000 rpm for 10 min at 4 °C.
Immunoprecipitations were performed for 1 h at 4 °C, captured with
protein-G Sepharose for a further hour at 4 °C, and washed extensively
in Nonidet P-40 lysis buffer. GST-Ras binding assays were performed
using aGST-fusionprotein containing theRas bindingdomain of Raf that
was expressed in E. coli and puriﬁeduponGlutathione-Sepharosebeads.
Puriﬁed protein was added to cell lysates, incubated for 1 h at 4 °C, and
washed extensively in Nonidet-P40 buffer. Immunoprecipitations and
cell lysates were resolved by SDS-PAGE, Western blotted onto
polyvinylidenediﬂuoridemembranes (Millipore, Bedford,MA), blocked
in Tris Buffered Saline-0.1% Tween (TBS-T) containing 3% non-fat dried
milk, and immunoprobed in TBS-T with 1% non-fat dried milk. Blots
were stripped for30 minat55 °C (100 mM2-ME, 2%SDS, 62.5 mMTris–
HCl, pH 6.8) before reprobing. Proteins were detected with horseradish
peroxidase-conjugated secondary Abs and enhanced chemilumines-
cence (Pierce).
Fractionation
Pelleted cells were resuspended in 2 ml ice-cold hypotonic lysis
buffer (10 mM Tris–HCl (pH 7.5), 1 mM MgCl2, 1 mM sodium
orthovanadate) containing protease inhibitors (10 µg/ml aprotinin,
10 µg/ml leupeptin, 10 µg/ml pepstatin, 1 mM EDTA, 1 mM PMSF)
added immediately before use. After 30 min incubation on ice, lysis
was facilitated by Dounce homogenization for 12 strokes on ice, and
lysates were clariﬁed to remove nuclear material and intact cells.
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(P100) fraction was solublized in Nonidet P-40 lysis buffer containing
protease inhibitors.
Cell transfections and reporter assays
Cells were transfected with Lipofectamine 2000 (Invitrogen). For
reporter assays cells were transfected so that each well received
100 ng pFR-luciferase reporter plasmid, 200 ng pFA-Elk2 expression
plasmid, and 100 ng CMV-ß-galactosidase expression plasmid
(Lemercier et al., 2000). Cells were harvested after 19 h, and luciferase
activity and β-galactosidase activity were measured on a TR717
microplate luminometer using the Luciferase Assay System (Promega,
Madison, WI) and the Galactolight Plus System (Tropix, Bedford, MA)
according to the manufacturers’ protocols.
Anchorage-independent growth assay
MDA-MB-231 cells treated with RNA duplexes were plated at 2000
cells per 10 cm2 tissue culture dish in completeDMEMmedia containing
0.33%(w/v) agar as described (Valenzuela and Groffen, 1986). Cells
were incubated at 37 °C in 5% CO2 for 12 days, and colonies containing
N20 cells were counted.
Results
TAP-1 was expressed in multiple tissues
Mammalian genomes contain three TAP genes as deﬁned by the
presenceof sequencesencodingaCRAL/TRIOdomainamino-terminal to a
GOLD domain (Fig. 1A). These are located as gene clusters on
chromosomes 22 and 11 in humans andmice, respectively. To determine
the expression proﬁles of the TAP genes, we performed a qualitative RT-
PCRanalysis in a variety ofmouse tissues, utilizingprimers speciﬁc to each
isoform (Fig. 1B). All three TAP genes were expressed in one or more
tissues. TAP-1was themostwidely expressed, being present in four of the
seven tissues examined, including brain, kidney, lung, and spleen. TAP-2
wasdetected in the lungand thymus, andTAP-3wasdetected solely in the
lung. Due to its widespread expression, we chose to focus on TAP-1 as a
potential regulator of Ras-ERK signaling.Fig. 1. Expression proﬁles of TAP-1, TAP-2, and TAP-3. (A) The domain structure of TAP
proteins. (B) RNA puriﬁed from mouse tissues (brain, heart, kidney, lung, spleen and
thymus) and mouse ES cells was used to generate cDNA. Bands are ethidium bromide
stained fragments of DNA that were ampliﬁed from the cDNA using primers designed to
amplify TAP-1, TAP-2 and TAP-3. Primers that speciﬁcally ampliﬁed tubulin were used
as a control for the input cDNA, and this experiment demonstrated the presence of
ampliﬁable RNA in each tissue sample. To control for non-speciﬁc ampliﬁcation, we
analyzed control samples that contained RNA but no cDNA (Lung Ctrl), or contained no
RNA (water). TAP-1 was detected in brain, kidney, lung and spleen, TAP-2 was detected
in lung and thymus, and TAP-3 was detected only in lung. The TAP-1 and TAP-3 primers
generated a single band in all cases, whereas the TAP-2 primers generated two bands
from thymus tissue that may result from alternatively spliced transcripts.TAP-1 colocalized with Ras and Raf at the cell membrane
We analyzed the subcellular localization of TAP-1 in COS-7 cells
due to their easily distinguishable cellular morphology. Flag-Tagged
TAP-1was expressed in COS-7 cells and visualized by immunostaining
with an anti-Flag monoclonal antibody. The cytosol contained a
signiﬁcant amount of diffusely localized TAP-1 staining, whereas the
membrane of the cell contained brightly stained patches interspersed
with regions of little TAP-1 staining (Fig. 2A, D). To determine the
relationship between TAP-1 localization and Ras-ERK signaling
proteins, we co-expressed Flag-tagged TAP-1 with GFP tagged K-Ras
or H-Ras. Both K-Ras and H-Ras displayed areas of bright staining at
the cell membrane (Fig. 2B, E) that colocalized with TAP-1 (Fig. 2C, F).
Because these imaging experiments have limited resolution, these
results do not provide evidence that TAP-1 is physically associated
with Ras. Furthermore, these results do not directly establish the
subcellular localization of endogenous TAP-1 and Ras, since TAP-1 and
Ras proteins were over-expressed and epitope tagged to permit
visualization.
To determine if TAP-1 staining is affected by ligand activation of
the signaling pathway, we visualized TAP-1 staining in cells treated
with EGF. TAP-1 staining was not affected by EGF treatment,
indicating that TAP-1 localization at the membrane occurs in a ligand
independent manner (Fig. 2G, J). In contrast, a GFP-tagged form of
Raf-1 was recruited to the cell membrane following treatment with
EGF (Fig. 2H, K), indicating that the over-expressed and epitope
tagged Raf displays normal localization and ligand responsiveness.
When Raf is recruited to the membrane, it colocalized with the
membrane pool of TAP-1 (Fig. 2L). These results support the model
that TAP-1 may operate at the cell membrane to affect Ras-ERK
signaling.
Endogenous TAP-1 negatively regulated Ras-ERK signaling in cancer cell
lines
Having established that TAP-1 colocalizes with Ras and Raf, we
wanted to determine if endogenous TAP-1 regulates Ras signaling.We
identiﬁed that the MDA-MB-231 breast carcinoma and A549 lung
carcinoma cancer cell lines express measurable levels of TAP-1
transcript. These cell lines contain mutationally activated oncogenic
K-Ras and thus provide a sensitized background to examine the
effects of TAP-1 gene silencing (Valenzuela and Groffen, 1986;
Gilhooly and Rose, 1999).
We identiﬁed three mutually exclusive RNA duplexes that
signiﬁcantly reduced the level of TAP-1 transcripts in MDA-MB-231
cells (Fig. 3A). These effects were observed in comparison to control
cells treated with no RNA (data not shown) and control cells treated
with a dsRNA that has a scrambled sequence (Fig. 3A)—this treatment
controls for physical effects that might be caused by transfecting small
RNA molecules. Treatment with RNA duplexes directed against TAP-1
also reduced the level of transfected TAP-1 protein (Fig. 3B). Because
this TAP-1 protein was over-expressed and epitope tagged, these
results do not directly demonstrate the extent of the effect on
endogenous TAP-1 protein. To analyze the function of endogenous
TAP-1 in the Ras signaling pathway, we measured the effect of
reducing TAP-1 gene expression upon the level of phosphorylation of
endogenous ERK. Reducing TAP-1 gene expression increased ERK
phosphorylation but did not affect the level of total ERK (Fig. 3C).
Because this effect was observed with three mutually exclusive RNA
duplexes, the effect is likely caused by speciﬁcally reducing TAP-1
gene expression and is unlikely to be mediated by off-target effects.
To determine if TAP-1 regulates ERK signaling in additional cell
types, we examined the A549 lung carcinoma cell line. Treatment
with two mutually exclusive RNA duplexes reduced the levels of TAP-
1 transcripts (Fig. 4A). Reducing TAP-1 gene expression also increased
the level of phosphorylated ERK in A549 carcinoma cells (Fig. 4B).
Fig. 2. TAP-1 colocalized with Ras and Raf-1 at the plasma membrane. Flag-TAP-1 and GFP-K-Ras (A-C), GFP-H-Ras (D-F) or GFP-Raf-1 (G-L) were expressed in COS-7 cells and
visualized by confocal microscopy. Panels illustrate 1 to 3 representative cells. Cells were either untreated (A–I) or treated with 20 ng/ml EGF for 5 min (J, K, L). Yellow in the merged
images represents patches of colocalization between Flag-TAP-1 (red) and GFP-Ras or GFP-Raf (green). Arrows indicate patches of Flag-TAP-1 at the cell membrane (G), or patches of
colocalization of TAP-1 with GFP-Ras (C, F) or Raf (L) at the cell membrane.
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sensitized system to examine Ras-ERK signaling, and we demonstrat-
ed that HeLa cells express endogenous TAP-1 transcripts that can be
silenced with RNA duplexes (Fig. 5A). Reducing TAP-1 gene
expression increased the level of phosphorylated ERK in HeLa cells
expressing an activated form of K-Ras, but had minimal effects on the
level of phosphorylated ERK in HeLa cells expressing wild-type K-Ras
(Fig. 5B). In this experimental system, the effects of reducing TAP-1
activity were evident only in cells with an activated mutant form of
Ras. In contrast to theMDA-MB-231 and A549 cell lines, we noted that
Ras signaling in HeLa cells was sensitive to the α-tocopherol. Notably,
α-tocopherol inhibited ERK phosphorylation in HeLa cells expressing
oncogenic K-Ras, such that cells treated with 100 μg/ml α-tocopherol
displayed lower levels of ERK phosphorylation than untreated cells
(Fig. 5B). Importantly, reducing TAP-1 gene expression abrogated this
effect, making ERK phosphorylation independent of α-tocopherol
treatment. These ﬁndings indicate that Ras, TAP-1 and α-tocopherol
may functionally interact in speciﬁc cellular environments.
The following evidence indicates that treatment with dsRNA
directed against TAP-1 caused a substantial and speciﬁc reduction of
TAP-1 gene activity; the treatment reduced the levels of tap-1 mRNA
and epitope-tagged TAP-1 protein, and three different, non-over-
lapping dsRNA molecules directed against TAP-1 caused similar
alterations in ERK phosphorylation. Importantly, our studies show
that reducing endogenous TAP-1 gene expression increased Ras-ERK
signaling in three different types of cells with mutationally activated
Ras, demonstrating that these effects are not speciﬁc to a singlecell type: HeLa cells with exogenously expressed oncogenic K-Ras,
breast carcinoma cells and lung carcinoma cells.
TAP-1 regulated the recruitment of Raf to membrane-bound Ras
Having identiﬁed an important functional role for endogenous TAP-
1,we performed a biochemical analysis to further delineate the position
in the signaling pathway affected by TAP-1. To analyze the effect of TAP-
1 on the functionof Raf,we performed three independent assays.MEK is
phosphorylated by Raf following the recruitment of Raf to the plasma
membrane by GTP-bound Ras. Therefore, phosphorylation of MEK is a
relevant and speciﬁc indication of Raf activity. MEK phosphorylation
was monitored using an antibody that speciﬁcally recognizes phos-
phorylatedMEK. Reducing the level of TAP-1 gene expression increased
phosphorylation of MEK, indicating that endogenous TAP-1 negatively
regulates the kinase activity of Raf (Fig. 3C). To determine if TAP-1
affects Raf-1 recruitment to the plasma membrane, we performed a
cellular fractionation using high speed centrifugation andmeasured the
amount of Raf-1 present in the membrane-enriched pellet and in the
cytosol-enriched supernatant. An increased amount of Raf-1 was
associated with the membrane fraction of cells with reduced levels of
TAP-1 gene expression (Fig. 6A). Furthermore, an increased amount of
MEK was associated with the membrane, suggestive that reducing the
level of TAP-1geneexpression increases the levels of functionalRas-ERK
signaling complexes at the cell membrane. Conversely the amount of
Ras associated with the membrane fraction was unaffected by the
reduction of TAP-1 gene expression, indicating that the accumulation of
Fig. 3. Endogenous TAP-1 affected Ras signaling inMDA-MB-231 breast carcinoma cells.
MDA-MB-231 cells were transfected with a non-targeting RNA duplex (Ctrl) or the
TAP-1 speciﬁc RNA duplexes (A, B, C). (A) TAP-1 and tubulin transcript levels were
assessed by RT-PCR. Both TAP-1 and tubulin transcript levels were proportional to the
cDNA input, demonstrating the semi-quantitative nature of the assay. TAP-1 transcript
levels were signiﬁcantly reduced by the speciﬁc targeting duplex, compared to the
control non-targeting duplex. (B) MDA-MB-231 cells were transfected with a non-
targeting RNA duplex or the TAP-1 speciﬁc RNA duplexes. After 48 h cells were
transfected with a plasmid expressing Flag-tagged human TAP-1, and exogenous TAP-1
expression was monitored 48 h later with anti-Flag immunoblotting. Protein loading
was conﬁrmed with anti-Ras immunoblotting. All three TAP-1 RNA duplexes caused a
striking reduction of TAP-1 protein levels. (C) Lysates were immunoprobed for
phosphorylated ERK (pERK), total ERK (ERK), phosphorylated MEK (pMEK), total MEK
(MEK), and Ras. α-tocopherol-treated cells were exposed to 100 μg/ml of α-
tocopherol; this treatment did not affect ERK phosphorylation.
Fig. 4. Endogenous TAP-1 affected phosphorylation of ERK in A549 lung carcinoma cells.
A549 cells were transfected with a non-targeting RNA duplex (Ctrl) or the TAP-1
speciﬁc RNA duplexes (A, B). (A) TAP-1 and tubulin transcript levels were assessed by
RT-PCR. Both TAP-1 and tubulin transcript levels were proportional to the cDNA input,
demonstrating the semi-quantitative nature of the assay. TAP-1 transcript levels were
signiﬁcantly reduced by the speciﬁc targeting duplexes, compared to the control non-
targeting duplex. (B) Cell lysates were immunoprobed for endogenous phosphorylated
ERK (pERK) and total ERK (ERK). Reducing the level of TAP-1 transcripts caused an
increase in the level of phosphorylated ERK and did not affect the level of total ERK.
Cells were exposed to 0, 10, or 100 μg/ml of α-tocopherol; this treatment did not affect
ERK phosphorylation.
Fig. 5. Endogenous TAP-1 affected oncogenic Ras signaling in HeLa cells. (A) A non-
targeting RNA duplex (Control) or the TAP-1 speciﬁc RNA duplex (TAP-1[C]) were
transfected into HeLa cells. TAP-1 and tubulin transcript levels were assessed by RT-
PCR. Both TAP-1 and tubulin transcript levels were proportional to the cDNA input,
demonstrating the semi-quantitative nature of the assay. TAP-1 transcript levels were
signiﬁcantly reduced by the speciﬁc targeting duplex, but not by the control non-
targeting duplex. (B) HeLa cells were transfected with a control RNA duplex (−), or
with TAP-1-speciﬁc RNA duplex C (+). After 48 h, cells were transfected with plasmids
expressing wild-type or oncogenically mutated K-Ras. After 24 h, cells were exposed to
α-tocopherol. Lysates were immunoprobed as indicated.
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membrane.
To determine if reducing the level of TAP-1 gene expression
increased the association of Raf with Ras, we directly examined the
amount of Raf-1 associated with Ras by coimmunoprecipitation. The
coimmunoprecipitation was performedwith a commercially available
anti-Ras antibody, and Western blots were used to demonstrate that
the antibody recognizes endogenous Ras protein (Fig. 6). A compar-
ison of cells treated with control dsRNA and dsRNA directed against
TAP-1 showed that reducing the level of TAP-1 gene expression
increased the association of Raf-1 with Ras (Fig. 6B). The total level of
Raf-1 association with Ras might be enhanced by an increase in the
fraction of Ras that is GTP-loaded, or by an increased propensity of
Raf-1 to associate with GTP-loaded Ras. To distinguish between these
possibilities, we assessed the fraction of Ras that is GTP-loaded.Reducing the level of TAP-1 gene expression did not increase the
fraction of Ras that is GTP-loaded (Fig. 6C). Together these results
indicate that endogenous TAP-1 reduces the activity of Raf-1 by
reducing the propensity of Raf-1 to bind GTP-loaded Ras at the cell
membrane.
Fig. 6. Reducing TAP-1 gene expression increased Raf-1 association to Ras. MDA-MB-231
cells were transfectedwith a control RNA duplex orwith one of three different TAP-1 RNA
duplexes that reduce endogenous TAP-1 gene expression. (A) Cells were fractionated, and
aliquots of the membrane (P100) and cytosolic (S100) fractions were immunoprobed as
indicated. The fractionation was conﬁrmed by analyzing the transferrin receptor (TfR),
which was only detected in the membrane fraction. (B) Ras association with Raf-1 was
assessed by immunoprecipitating Ras and immunoprobing for Raf-1. (C) The fraction of
GTP-loaded Ras was determined by afﬁnity chromatography with a GST fusion protein
containing the Ras-binding domain of Raf-1 (upper panel), and compared to the total level
of Ras in the lysate (lower panel).
Fig. 7. Reducing TAP-1 gene expression increased Ras-ERK signaling activity. MDA-MB-
231 cells were transfected with a control RNA duplex, or with one of two different TAP-1
RNA duplexes that reduce endogenous TAP-1 gene expression. (A) After 48 h, cells were
transfected with Elk1-luciferase expression plasmids, and signaling activity was assessed
after 48 h. (B) After 48 h, cells were plated in soft agar, and the number of colonies was
determined after 12 days. Error bars are standard deviations of three transfections
conducted in parallel.
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The biochemical analyses of Ras, Raf, MEK and ERK demonstrated
that TAP-1 modulates this signaling pathway. To determine the
signiﬁcance of modulation by TAP-1, we analyzed two downstream
effects of Ras signaling, transcription and cell proliferation. Transcrip-
tion controlled by Ras-ERK signaling was monitored using a reporter
assay that measures luciferase activity driven by ERK-mediated
phosphorylation of the Elk-1 transcription factor. Reducing the level
of TAP-1 gene expression in MDA-MB-231 cells enhanced the
activation of an Elk-1-luciferase reporter construct 2 to 3 fold
(Fig. 7A). These results demonstrate that endogenous TAP-1 is
necessary for normal levels of Ras-ERK signaling, and the effects on
transcriptional control can be readily observed.
Oncogenic Ras signaling increases the ability of cells to form
colonies in semi-solid media (Clark et al., 1995).We took advantage of
this cellular assay to determine if changes in Ras activity arising from
decreases in TAP-1 gene expression are functionally signiﬁcant.
Reducing TAP-1 gene expression increased the number of colonies
formed in soft agar by approximately 3-fold (Fig. 7B). These results
suggest that endogenous TAP-1 suppresses the oncogenic capacity of
cancer cells in vitro.Discussion
TAP-1 regulates Raf-1 availability to GTP-loaded Ras at the cell
membrane
Despite intense investigation into the Ras/Raf/ERK pathway, the
biochemical events required for efﬁcient Raf activation still remain
enigmatic. Here we demonstrate that a process that was known to be
required for efﬁcient Raf activation, the ability of Raf to translocate from
the cellular cytosol to the membrane microenvironment, is regulated by
TAP-1. The best-characterized aspect of Raf activation is its physical
interaction with Ras. Within the cytoplasm, Raf is maintained in an auto-
inhibitory conformation mediated by the interaction of the C1 amino-
terminal domain with the carboxy-terminal kinase domain (Cutler et al.,
1998). 14-3-3 proteins binding to phosphorylated serine residues of Raf
may stabilize this conformation,which canbe alteredby the activity of the
PP2A phosphatase, either before or following recruitment to the cell
membrane (Ory et al., 2003). Recently the CNK adaptor protein has been
identiﬁed as a critical regulator of Raf activity; CNK may work in concert
with the modulator KSR to regulate Raf activity through undeﬁned
allosteric mechanisms operating at the cell membrane (Douziech et al.,
2006). TheRasBindingDomain (RBD)ofRaf speciﬁcally bindsGTP-loaded
Ras and is situated in tandemwith a cysteine rich domain that provides a
second Ras binding site (Wellbrock et al., 2004; Chong et al., 2003; Fabian
et al., 1994;Brtva et al., 1995).Oncebound toRas, Rafmust adopt a state of
increased kinase activity, a process that is poorly understood but which
likely involves a number of allosteric changes and post-translational
modiﬁcations (Wellbrock et al., 2004; Douziech et al., 2006). Because it is
clear that the interaction with Ras is essential for Raf activation,
470 K.G. Johnson, K. Kornfeld / Developmental Biology 341 (2010) 464–471understanding themechanisms that enableRaf toaccessRasat the cellular
membrane is of critical importance. However, the mechanisms that
regulate the equilibrium of Raf distribution between the membrane and
cytosolic compartments are not well deﬁned, and this represents a
signiﬁcant gap in our understanding of Raf biology.
Reducing the expression of TAP-1 in human cancer cell lines
enhancesRaspathway signaling, demonstratedby the increased activity
of a Ras-dependent transcriptional reporter and by the increased
phosphorylation of two downstream kinases, MEK and ERK. Impor-
tantly, decreasing the expression of TAP-1 increased the recruitment of
Raf-1 to the cellmembraneand increased theamountof Raf-1physically
associated with Ras, independent of Ras GTP-loading. We conclude that
endogenous TAP-1 modulates Ras pathway signaling by regulating the
ability of Raf-1 to bind GTP-Ras at the cell membrane. This role of TAP-1
is functionally signiﬁcant, as reducing TAP-1 expression increased Ras-
dependent colony formation of the MDA-MB-231 human cancer cell
line in soft agar. Thus, these studies reveal that TAP-1 functionally
modulates Ras signaling and identify the regulation of an important step
of Ras/Raf signaling.
A physiological function for the TAP family of proteins
CGR-1was discovered as a regulator of Ras-mediated vulval cell fate
speciﬁcation in C. elegans (Goldstein et al., 2006). We have identiﬁed
TAP-1 to be a functional ortholog of CGR-1, consistent with the
hypothesis that CRAL/TRIO and GOLD domain containing proteins
contribute to the regulation of the Ras signaling pathway.While genetic
studies of C. elegans identiﬁed the function of CGR-1 in Ras signaling,
they were unable to deﬁne precisely where CGR-1 exerted its effect.
Here we advance this understanding by identifying the precise point at
which this family of CRAL/TRIO and GOLD domain containing proteins
affects Ras signaling, by demonstrating that TAP-1 acts at the level of Raf
recruitment to Ras.
The identity of the speciﬁc hydrophobic ligand for TAP-1 remains
controversial. TAP-1 was originally identiﬁed by its ability to catalyze
the cholesterol biosynthetic pathway in liver microsomes and can bind
squalene in vitro (Tchen and Bloch, 1957). However, C. elegans is unable
to synthesize cholesterol, discounting this as a function of CGR-1 in vivo.
TAP-1 was also identiﬁed through its ability to bind α-tocopherol in
vitro, leading to the suggestion that it may function as an α-tocopherol
transporter (Kempna et al., 2003). Interestingly, α-tocopherol and its
analogs negatively regulate oncogenic Ras signaling (Donapaty et al.,
2006;Ni et al., 2005). Theseﬁndings raise the interestingpossibility that
TAP-1 may mediate the effects of α-tocopherol on Ras signaling. Our
results indicate thatα-tocopherol and TAP-1may interact in HeLa cells,
but this interaction was not observed in two other cell lines.
In C. elegans, loss-of-function mutations of cgr-1 reduce Ras-mediated
signaling, indicating that CGR-1 positively regulates Ras signaling (Gold-
stein et al., 2006). Here we show that endogenous TAP-1 negatively
regulates Ras signaling in speciﬁc cell types. CGR-1 and TAP-1 may
function in both positive and negative manners depending upon the
cellular context. This is analogous to the regulation of the ETS domain
transcription factor LIN-1 in C. elegans, which acts as both a positive and
negative regulator of the vulval cell fate (Tiensuu et al., 2005; Leight et al.,
2005). Elk-1, a mammalian homologue of LIN-1, was originally identiﬁed
as a positive regulator of transcription, but also possesses negative
regulatory functions, much like LIN-1 (Yang and Sharrocks, 2004).
Alternatively, the functions of TAP-1 and CGR-1 may have diverged
during evolution so that CGR-1 is now primarily a positive regulator of
signaling whereas TAP-1 is primarily a negative regulator of signaling.
TAP-1 regulation of Ras signaling
Exactly how TAP-1 affects Raf activation remains to be fully deﬁned.
TAP-1 may inﬂuence Raf activity either prior to, or following, the binding
of Raf to Ras, by inﬂuencing either the formation or the dissociation of thesignaling complex. TAP-1may physically impinge upon the interaction of
Raf and Ras in amanner analogous to SUR-8 (Li et al., 2000), althoughwe
have been unable to detect any physical interactions between TAP-1 and
Ras or Raf-1. Alternatively, TAP-1 may act upon Raf prior to cellular
activation, either regulating the ability of Raf to translocate to the
membrane or by priming Raf within the cytosol to make it more or less
able to bind to Ras. Finally, TAP-1 may have lipid exchange activity as
proposed for other CRAL/TRIO domain proteins (Phillips et al., 1999). In
this case TAP-1may regulate the lipid environment at the cell membrane,
either increasing or decreasing the concentration of speciﬁc hydrophobic
molecules, and these changesmay inﬂuence the interactionofRas andRaf.
We have demonstrated that the biological activities of TAP-1 and Raf
activation are interlinked, and favor amechanismwhere these molecular
components constitute a critical aspect of Ras biology. The biological
function of TAP-1 has previously remained undeﬁned. We have now
discovered a role for TAP-1 in vivo and identiﬁed amajor newaspect of Raf
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